Risk of hypovolemia associated with sodium–glucose cotransporter-2 inhibitors treatment: A meta-analysis of randomized controlled trials

Risk of hypovolemia associated with sodium–glucose cotransporter-2 inhibitors treatment: A meta-analysis of randomized controlled trials

Aim of the reviewTo assess the risk of hypovolemia for sodium–glucose cotransporter-2 (SGLT2) inhibitors treatment.MethodA systematic literature retrieval was performed in PubMed, Embase, Cochrane Central Register of Controlled Trials (CENTRAL), Web of Science, and Scopus from inception up to 4 Octo...

Full description

Bibliographic Details
Main Authors: Xi Rong, Yawen Zhu, Bo Wen, Kai Liu, Xinran Li, Qiling Gou, Xiaoping Chen
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-11-01
Series:Frontiers in Cardiovascular Medicine
Subjects:
sodium-glucose cotransporter-2 inhibitors
adverse event (AE)
volume depletion
meta-analysis
RCTs
hypovolemia
Online Access:https://www.frontiersin.org/articles/10.3389/fcvm.2022.973129/full

Internet

https://www.frontiersin.org/articles/10.3389/fcvm.2022.973129/full

Similar Items